Oncolytics Biotech (ONCY) and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at SITC
Go back to Oncolytics Biotech (ONCY) and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at SITC| Bank of Commerce (NASDAQ: ONC) | Delayed: 274.91 +3.11 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $271.80 | 52 Week High | $0.35 | |||
| Open | $269.72 | 52 Week Low | $0.35 | |||
| Day High | $275.84 | P/E | N/A | |||
| Day Low | $269.53 | EPS | $0.00 | |||
| Volume | 103,475 | |||||
| (AMEX: ONCWF) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 148 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.94 +0.02 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.92 | 52 Week High | $1.37 | |||
| Open | $0.91 | 52 Week Low | $0.24 | |||
| Day High | $0.96 | P/E | N/A | |||
| Day Low | $0.91 | EPS | $0.00 | |||
| Volume | 351,185 | |||||

